Provided by Tiger Trade Technology Pte. Ltd.

Inhibrx Biosciences

103.63
+4.484.52%
Volume:220.74K
Turnover:22.72M
Market Cap:1.52B
PE:-11.67
High:105.65
Open:100.76
Low:99.05
Close:99.15
52wk High:155.29
52wk Low:24.27
Shares:14.67M
Float Shares:8.64M
Volume Ratio:0.75
T/O Rate:2.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.8768
EPS(LYR):-9.0434
ROE:-1773.60%
ROA:-43.61%
PB:-28.70
PE(LYR):-11.46

Loading ...

Mar 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 06, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 06, 2023

Major Issues Report

8-K - Current report
Mar 06, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 16, 2022

Major Issues Report

8-K - Current report
Nov 07, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2022

Major Issues Report

8-K - Current report
Oct 26, 2022

Major Issues Report

8-K - Current report
Oct 17, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 04, 2022

Major Issues Report

8-K - Current report
Sep 23, 2022

Correspondence

CORRESP [Cover] - Correspondence
Aug 15, 2022

Major Issues Report

8-K - Current report
Aug 10, 2022

Major Issues Report

8-K - Current report
Aug 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2022

Major Issues Report

8-K - Current report
Jul 19, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 30, 2022

Major Issues Report

8-K - Current report